Literature DB >> 33025559

METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease.

Rong-Hua Song1, Xue-Rong Liu1, Chao-Qun Gao1, Peng Du1, Jin-An Zhang2.   

Abstract

PURPOSE: Autoimmune thyroid disease (AITD) is a classic autoimmune disorder that mainly includes Graves' disease (GD) and Hashimoto's thyroiditis (HT). In this study, we explored the potential relationship between single-nucleotide polymorphisms (SNPs) of methyltransferase like 3 (METTL3) gene and the development of AITD.
METHODS: The distribution of METTL3 genotypes at seven loci (rs1139130, rs1263790, rs1263791, rs17197156, rs2242526, rs3752411, and rs4417466) in 960 AITD (599 GD and 361 HT) patients and 732 unrelated healthy volunteers was examined using high-throughput sequencing technology in a case-controlled manner and their correlations with AITD development were statistically analyzed.
RESULTS: METTL3 genotypes at these seven SNPs were not correlated with both GD and HT except a borderline association between rs3752411and GD after adjusted for age, sex, and thyroid function under the recessive model. Subgroup analysis demonstrated that the minor allele frequencies of rs2242526 and rs4417466 were higher in male AITD patients than in healthy volunteers before adjusted for confounding factors and the genotype distribution of rs4417466 was significantly different between the two groups. Additionally, the genotype frequencies of rs1139130, rs1263791, rs2242526, and rs4417466 were positively related with GD in male patients. Likewise, the allele distribution of rs1263791, rs2242526, and rs4417466 in male GD patients differed significantly from that in male controls. Multivariate logistic regression analyses revealed a significant association between allele frequencies of these three loci and GD in male patients after adjusted for the confounding factors. Moreover, the genotype of rs3752411 was strongly associated with GD in females as well. Furthermore, distribution of rs3752411 genotype was significantly associated with hypothyroidism in HT patients.
CONCLUSION: Our study for the first time revealed a strong correlation between METTL3 mutations and AITD predisposition, implying that METTL3 may be a new candidate gene for AITD treatment.

Entities:  

Keywords:  Autoimmune thyroid disease (AITD); Graves’ disease (GD); Hashimoto’s thyroiditis (HT); METTL3; Polymorphism

Mesh:

Substances:

Year:  2020        PMID: 33025559     DOI: 10.1007/s12020-020-02503-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  4 in total

1.  Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Authors:  Rong-Hua Song; Zhi-Yun Yu; Qiu Qin; Xuan Wang; Fatuma-Said Muhali; Liang-Feng Shi; Wen-Juan Jiang; Ling Xiao; Dan-Feng Li; Jin-An Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Aberrant Histone Methylation in Patients with Graves' Disease.

Authors:  Ni Yan; Kaida Mu; Xiao-Fei An; Ling Li; Qiu Qin; Rong-Hua Song; Qiu-Ming Yao; Xiao-Qing Shao; Jin-An Zhang
Journal:  Int J Endocrinol       Date:  2019-06-24       Impact factor: 3.257

3.  METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-κB Signaling Pathway.

Authors:  Jinghua Wang; Shushan Yan; Hongying Lu; Shufeng Wang; Donghua Xu
Journal:  Mediators Inflamm       Date:  2019-10-24       Impact factor: 4.711

Review 4.  The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.

Authors:  Bin Wang; Xiaoqing Shao; Ronghua Song; Donghua Xu; Jin-An Zhang
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

  4 in total
  2 in total

1.  METTL3 Is Involved in the Development of Graves' Disease by Inducing SOCS mRNA m6A Modification.

Authors:  Rong-Hua Song; Peng Du; Chao-Qun Gao; Xue-Rong Liu; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-20       Impact factor: 5.555

Review 2.  An Update Evolving View of Copy Number Variations in Autoimmune Diseases.

Authors:  Rong-Hua Song; Chao-Qun Gao; Jing Zhao; Jin-An Zhang
Journal:  Front Genet       Date:  2022-01-20       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.